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Abstract
Objective: Despite excellent survival prognosis, children treated for craniopharyngioma experience
significant morbidity. We examined the role of hypothalamic involvement (HI) in excessive daytime
sleepiness (EDS) and attention regulation in children enrolled on a Phase II trial of limited surgery
and proton therapy. Methods: Participants completed a sleep evaluation (N¼ 62) and a continuous
performance test (CPT) during functional magnetic resonance imaging (fMRI; n¼ 29) prior to proton
therapy. Results: EDS was identified in 76% of the patients and was significantly related to increased
HI extent (p¼ .04). There was no relationship between CPT performance during fMRI and HI or EDS.
Visual examination of group composite fMRI images revealed greater spatial extent of activation in
frontal cortical regions in patients with EDS, consistent with a compensatory activation hypothesis.
Conclusion: Routine screening for sleep problems during therapy is indicated for children with cra-
niopharyngioma, to optimize the timing of interventions and reduce long-termmorbidity.
Key words: cancer and oncology; neuropsychology; sleep.
Craniopharyngiomas are intracranial tumors of low
histological grade that arise during embryonic devel-
opment (Garre & Cama, 2007) and account for 6% of
all intracranial tumors diagnosed during childhood
(NCI, 2015). Despite 5- and 10-year survival rates
greater than 90% (NCI, 2015), survivors experience
substantial long-term morbidity.
Treatment approaches for craniopharyngioma may
include surgical resection with or without adjuvant ra-
diation therapy. Maximal surgical resection is done
with the goal of preventing tumor recurrence and min-
imizing the need for adjuvant therapy; however, this
approach may result in substantial morbidity from
damage to proximal neural structures, including the
optic chiasm, hypothalamus, and mammillary bodies.
Conservative surgical resection is attempted with the
goal of relieving symptoms while preserving the func-
tion of surrounding neural structures; however, these
patients frequently require adjuvant radiation therapy
to treat residual tumor or subsequent progression.
VC The Author 2016. Published by Oxford University Press on behalf of the Society of Pediatric Psychology.
All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 610
Journal of Pediatric Psychology, 41(6), 2016, 610–622
doi: 10.1093/jpepsy/jsw026
Advance Access Publication Date: 16 May 2016
Original Research Article
The consequences of central nervous system (CNS)-
directed radiation therapy for treatment of CNS
malignancies are well-known and include endocrino-
pathies, neurocognitive deficits, second malignancies,
and damage to microvasculature that is associated
with increased risk for later ischemic events. There is a
need to reduce the deleterious impact of disease and
treatment, so as to promote a high quality of life.
Studies that clarify the onset and trajectory of adverse
functional outcomes in survivors of childhood cranio-
pharyngioma will inform treatment modifications, im-
prove caregiver education to facilitate treatment
decision-making, and inform interventions to amelior-
ate difficulties and improve quality of life.
Craniopharyngiomas are located in the sellar region
of the brain and have both cystic and solid compo-
nents. These tumors often involve or displace the optic
chiasm, pituitary gland, and hypothalamus. Visual im-
pairment, pituitary dysfunction, and endocrinopathies
are frequently present at diagnosis (Muller, 2008).
Notably, disruption of hypothalamic-pituitary func-
tion is present in 52–87% of cases (Muller, 2008).
Symptoms including visual impairment and hydro-
cephalus related to tumor expansion may improve fol-
lowing surgical intervention (Caldarelli, Massimi,
Tamburrini, Cappa, & Di Rocco, 2005). In contrast,
symptoms of hypothalamic dysfunction, including
obesity, behavior changes, fatigue, and sleep dysfunc-
tion, have been found to persist in 65–80% of patients
following treatment (Poretti, Grotzer, Ribi, Schonle,
& Boltshauser, 2004).
A retrospective study reported clinically significant
rates of self-reported insomnia symptoms and poor
sleep efficiency in 25% of adult survivors of childhood
brain tumors (Zhou, Manley, Marcus, & Recklitis,
2016). Another study found that compared with a
population-based group matched for age, sex, and zip
code, adult survivors of childhood brain tumors were
2.7 times more likely to report sleep-onset problems
(Nolan et al., 2013). Clinically significant rates of fa-
tigue or excessive daytime sleepiness (EDS) have been
identified in up to one-third of adult survivors of pedi-
atric craniopharyngioma (Muller et al., 2006; Poretti
et al., 2004). Endocrine deficits and obesity due to
metabolic dysfunction may contribute to obstructive
sleep apnea, which further impacts sleep quality
(Muller, 2010). Results from a case series of three ado-
lescent survivors of craniopharyngioma with self-re-
ported daytime hypersomolence found significantly
lower mean 24-hr plasma melatonin levels as com-
pared with historical controls (Lipton et al., 2009).
Another study found that lower melatonin levels cor-
related with increased self-reported fatigue in sur-
vivors (Muller, Handwerker, Wollny, Faldum, &
Sorensen, 2002). Impairments in melatonin secretion
are important to consider, as melatonin is a hormone
primarily related to sleep onset as well as appropriate
circadian rhythmicity (Gooley, 2011). Pre- and
post-surgical hypothalamic tumor involvement (HI) is
associated with adverse long-term outcomes in several
domains (de Vile et al., 1996; Muller et al., 2011;
Sterkenburg et al., 2015). Given the critical role of the
hypothalamus in the regulation of biological and cir-
cadian rhythms, it is reasonable to hypothesize an as-
sociation between HI and sleep outcomes in survivors
of craniopharyngioma.
Importantly, healthy, adequate sleep is essential in
memory consolidation, attentional processing, execu-
tive function, and emotion regulation (Astill, Van der
Heijden, Van Ijzendoorn, & Van Someren, 2012;
Born & Wilhelm, 2012; Walker & van der Helm,
2009; Weissman, Roberts, Visscher, & Woldorff,
2006). Furthermore, adequate sleep has been demon-
strated to be critical for both tissue renewal and recov-
ery of neural processes. Sleep difficulties in children
undergoing treatment for CNS tumors are particularly
important to address, as sleep disruption has been
found to be related to tumor growth in mouse models
(Clanton et al., 2011; Hakim et al., 2014; Mandrell
et al., 2012). With the vulnerability to deficits in these
areas in pediatric CNS tumor patients, it is unknown
at this time what additional role healthy sleep may
play in neurocognitive performance.
The majority of studies examining neurocognitive
outcomes in patients treated for childhood cranio-
pharyngioma have documented evidence of disease
and treatment-related deficits in specific domains,
including executive function and memory
(Carpentieri et al., 2001; Di Pinto, Conklin, Li, &
Merchant, 2012; Waber et al., 2006), although stud-
ies examining global outcomes (e.g., intelligence) do
not consistently find problems (Pierre-Kahn et al.,
2005). Compared with age- and gender-matched
controls, adult survivors of childhood craniophar-
yngioma had significantly worse performance on
measures of attention, processing speed, and mem-
ory, and increased HI was found to be predictive of
worse performance in the patient group (Fjalldal
et al., 2013). In a study of 15 craniopharyngioma
survivors, Ozyurt and colleagues found that patients
with more extensive post-surgical hypothalamic le-
sions performed worse on measures of executive
function and adaptive skills (Ozyurt, Thiel, et al.,
2014). Studies using functional magnetic resonance
imaging (fMRI) to examine the neural mechanisms
underlying cognitive and behavioral deficits in sur-
vivors have found altered patterns of neural activa-
tion in frontal cortical regions that have been
demonstrated to receive direct or indirect input
from the hypothalamus (Lemaire et al., 2011).
Ozyurt and colleagues showed that hypothalamic
damage resulted in altered neural activation in the
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medial prefrontal cortex during an emotional face
recognition task in a cohort of 10 survivors com-
pared with 10 healthy controls matched for age
(Ozyurt, Lorenzen, et al., 2014).
Taken together, these findings document increased
risk for sleep disruption and neurocognitive deficits in
survivors of childhood craniopharyngioma. Studies of
sleep outcomes are generally focused on long-term
outcomes using retrospective design or case series.
Studies using fMRI to examine neural mechanisms in
craniopharyngioma are limited by small cohorts.
Prospective studies are needed to clarify the onset and
trajectory of morbidity. Further specification of the
neural mechanisms underlying cognitive deficits may
inform treatment decision-making and intervention.
The current study prospectively examines the im-
pact of HI in sleep and neurocognitive performance in
children undergoing treatment for craniopharyngioma
in the context of a Phase II trial of limited surgical re-
section and proton therapy. We have previously dem-
onstrated that more than half of these patients meet
criteria for EDS on a multiple sleep latency test
(MSLT) before treatment with proton therapy and
that patients with two or more sleep-onset REM peri-
ods (SOREMP) on MSLT performed significantly
worse on global and specific measures of intelligence
when compared with patients with fewer than two
sleep-onset REMs (Graef et al. 2015). This is an im-
portant consideration, as EDS (as indicated by short-
ened sleep-onset latency [SOL] as well as SOREMP)
likely interferes with children’s ability to engage in
preferred and social activities and may have a negative
impact on academic performance, adjustment, and
other aspects of daily functioning following comple-
tion of treatment for CNS tumors (Gapstur, Gross, &
Ness, 2009; Mandrell et al., 2012; Rosen, Shor, &
Geller, 2008; Verberne, Maurice-Stam, Grootenhuis,
Van Santen, & Schouten-Van Meeteren, 2012).
We extend these findings by further clarifying the
association between sleep dysfunction and neurocog-
nition using fMRI and by examining the role of HI in
these outcomes before adjuvant proton therapy. We
hypothesized that greater extent of pre-surgical HI
would be associated with increased sleep dysfunction,
given prior research demonstrating that HI is a pre-
dictor of long-term sleep outcomes (de Vile et al.,
1996; Fjalldal et al., 2013; Muller, 2010). Our second
hypothesis was that patients with clinical symptoms of
hypothalamic dysfunction (i.e., EDS) or with more ex-
tensive of HI would demonstrate decreased perform-
ance compared with patients without EDS and those
with a less extensive HI, respectively, during an fMRI
task measuring attention regulation. Finally, we
hypothesized that patterns of neural activation would
differ between groups based on extent of HI and/or
the presence of EDS.
Method
Between March 2013 and July 2015, 80 individuals
diagnosed with childhood craniopharyngioma were en-
rolled in a multi-institutional, Phase II trial of proton
therapy for craniopharyngioma (ClinicalTrials.gov
Identifier: NCT01419067). Patients between 0 and 21
years of age were eligible for enrollment.
Craniopharyngioma was diagnosed by histology, cy-
tology, or neuroimaging. This study was approved by
the institutional review board. Informed consent and as-
sent were obtained for all protocol-based procedures.
Before receiving proton therapy, patients completed sev-
eral baseline correlative studies, including neurocognitive
testing, a sleep exam consisting of a clinical evaluation
by a pediatric sleep specialist plus nocturnal polysomog-
raphy (NPSG), and fMRI. All baseline correlative studies
were conducted at a single center (St. Jude Children’s
Research Hospital). Patients were excluded from neuro-
cognitive testing if they spoke no English or spoke
English as a second language or if they had a visual or
sensorimotor impairment that precluded participation.
Patients <6 years old were excluded from the baseline
sleep exam. Patients <8 years old were excluded from
fMRI exams. The analyses included in the current manu-
script are restricted to those patients meeting inclusion
criteria for the baseline sleep exam.
Table I details the demographic and clinical charac-
teristics for the overall cohort (N¼62) and stratified
by fMRI completion status (eligible and completed
scan¼þfMRI (n¼ 29); eligible and did not complete
scan¼fMRI (n¼ 10). Of the 64 patients meeting cri-
teria for this analysis, two did not complete the base-
line sleep exam (one¼ illness, one¼unknown). Sixty-
five percent of the overall group was White and 18%
were Black. The majority (82%) were not Hispanic or
Latino. Of the 25 participants in the þfMRI cohort
with available handedness data, 79% were right-
handed. Of the 62 participants who completed a sleep
study, 54 had surgery before the baseline cognitive as-
sessment (median time from surgery to assess-
ment¼2.55 months; range¼ 14 days to 3.7 years).
Clinical Variables
Demographic and clinical data were systematically
collected at baseline. HI was graded based on the ear-
liest available pre-surgical MRI scan, according to the
criteria proposed by Muller et al. (2011). Criteria
were as follows: Grade 0: no HI; Grade 1: involve-
ment of the anterior hypothalamus; and Grade 2: in-
volvement of the anterior and posterior hypothalamic
area (i.e., involving the mammillary bodies and the
area beyond the mammillary bodies).
Sleep Evaluation
Patients were seen and evaluated by a pediatric sleep
medicine specialist who reviewed a complete sleep
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history and performed a physical examination. Patients
completed an NPSG exam performed on their usual
sleep/wake schedule to assess sleep time, sleep stage dis-
tribution, and sleep efficiency, as well as to assess for
sleep-related breathing disorders or periodic limb
movements. The sleep evaluations were performed at a
sleep center accredited by the American Academy of
Sleep Medicine (AASM), conducted by experienced,
registered sleep technologists, and interpreted by a
board-certified sleep medicine physician. Exams were
initiated within 1 hr of the patient’s usual bedtime.
Data on brain activity, eye movement, muscle activity,
Table I. Demographic and Clinical Characteristics for the Overall Cohort and the Cohort Completing fMRI
MSLT (N¼62) þfMRI (n¼29) fMRI (n¼ 10) pa
% % % %
Sex 0.651
Male 51.6 51.7 60.0
Female 48.4 48.3 40.0
Hypothalamic involvement 0.242
Grade 0 12.9 17.2 20.0
Grade 1 30.6 37.9 10.0
Grade 2 56.5 44.8 70.0
Surgical procedure 0.196
Catheter only – craniotomy 4.8 10.3 10.0
Catheter only – burr hole 12.9 41.4 20.0
Resection – craniotomy 51.6 24.1 50.0
Resection – transphenoidal 17.7 24.1 20.0
None 12.9
Laterality 0.153
Left 12.9 4.5 30.0
Right 51.6 37.9 50.0
Midline 17.7 24.1 20.0
Bifrontal 4.8 10.3
CSF diversion 0.951
Yes 29 69.0 70.0
No 71 31.0 30.0
Diabetes insipidus 0.777
Yes 54.8 55.2 50.0
No 45.2 44.8 50.0
Visual acuity (right) 0.314
No deficits 67.7 79.3 60.0
Reduced, no functional impairment 16.1 13.8 40.0
Reduced, functional impairment 11.3 3.4
Blind 4.8 3.4
Visual acuity (left) 0.484
No deficits 69.4 86.2 70.0
Reduced, no functional impairment 9.7 6.9 20.0
Reduced, functional impairment 14.5 3.4
Blind 6.5 3.4 10.0
Excessive daytime sleepiness 0.045
Yes 75.8 69.0 100.0
No 24.2 31.0 .
Epworth Sleepiness Scale – Parentb 0.908
Impaired (total score >10) 40.4 37.9 60.0
Unimpaired (total score 9) 59.6 62.1 40.0
M6 SD M6 SD M6 SD
Age at exam 11.06 4.0 13.16 3.6 12.16 3.1 0.449
Full-Scale IQ 99.56 20.4 105.06 14.7 93.36 14.4 0.037
Total number of surgeries 1.46 1.0 1.06 0.8 1.66 0.8 0.044
MSLT mean sleep-onset latency 8.06 5.8 9.66 5.9 5.46 5.0 0.053
MSLT total number of SOREMP 1.26 1.4 0.76 1.1 2.06 1.6 0.006
Note. MSLT¼Multiple Sleep Latency Test; þfMRI¼ eligible and completed fMRI exam; fMRI¼ eligible and did not complete fMRI
exam; CSF¼ cerebrospinal fluid; SOREMP¼ sleep-onset REM periods. Hypothlamic involvement was assessed before surgical intervention.
Clinical and treatment variables reference procedures completed before study baseline. Surgical variables reference the most extensive proced-
ure completed before study baseline.
aTwo-sided p-value from comparisons betweenþ fMRI and fMRI cohorts.
bN¼52.
Sleep and Cognition in Children With Craniopharyngioma 613
and cardiac activity were collected using electroenceph-
alogram (two- to four-channel), electrooculogram
(two-channel), electromyogram (one-channel), and
electrocardiogram, respectively. Data were collected
with synchronized audio and video recording to docu-
ment behavior and to detect snoring and other ob-
structive sounds. Respiratory data were collected using
oro-nasal thermistors and/or nasal pressure trans-
ducers, and pulse oximetry. Some but not all patients
were evaluated with end-tidal CO2 pressure. The length
of the NPSG exams was commensurate with the pa-
tient’s usual sleep duration.
The MSLT is a standardized test used to evaluate
daytime sleepiness and measure sleep tendency in the
absence of alerting factors. Studies were performed ac-
cording to guidelines recommended by the AASM.
Patients were given four or five nap opportunities at
2-hr intervals throughout the day in a quiet darkened
room, with the exception of two patients with MSLT
exams limited to only two naps. Patients were
observed and instructed not to sleep at other times
throughout the day. If sleep onset occurred during a
nap opportunity, patients were allowed to sleep for
15 min before being awakened. If no sleep occurred
after 20 min, the nap opportunity ended. The mean
SOL was calculated as the arithmetic mean of all nap
opportunities; the number of naps and the number of
sleep-onset REM periods (SOREMP) were also re-
corded. EDS was defined as a mean SOL of 10 min
and/or 2 SOREMP.
A modified version of the Epworth Sleepiness Scale
(M-ESS) was administered to subjectively measure
daytime sleepiness (Moore et al., 2009). Caregivers
were asked to rank the propensity for the child or ado-
lescent to fall asleep in various everyday situations
(0¼ no chance to 3¼ high chance of dozing) for each
of the eight items, with a maximum score of 24.
Higher scores on the M-ESS indicate higher levels of
EDS. Consistent with recommendations of Melendres,
Lutz, Rubin, & Marcus (2004), a cut-off score of 10
reflected EDS (Melendres et al., 2004).
Neurocognitive Assessment
Participants completed a comprehensive neurocognitive
assessment at study baseline. As part of this assessment,
an age-standardized Full-Scale IQ (FSIQ) was derived
for each patient using an age-appropriate Wechsler
Intelligence Scale, with the majority completing the
Wechsler Intelligence Scale for Children, 4th Edition,
used for children aged 6 to 16 (Wechsler, 2003). These
data are included in the current study to characterize
global cognitive functioning for descriptive purposes.
MRI Exam
Participants completed an fMRI exam lasting 30–60 min
and consisting of four functional tasks. All patients
completed a video-based orientation and training pro-
gram before the exam. MRI exams were performed with
a 3T Siemens scanner using the standard quadrature
head coil. Functional images of the whole brain were ob-
tained with a T2*-weighted echoplanar imaging pulse
sequence (field of view¼192 mm; matrix¼64 64;
slice thickness¼5 mm; time to echo [TE]¼ 30 ms; 32 sli-
ces per volume). The acquisition time for one image vol-
ume (TR) was 2.06 s. High-resolution three-dimensional
T1-weighted images were acquired for anatomic visual-
ization (TR¼1.8 s, TE¼ 2.74 ms, flip angle¼ 15, voxel
size¼1 1 1 mm3).
The details of the continuous performance test
(CPT) task paradigm have been previously reported
(Ogg et al., 2008). A 10.3-s baseline period of fixation
was followed by four blocks with alternating periods
of task and fixation. The duration of task and fixation
periods was 20.6 s, and 10 imaging volumes were
acquired per period. During the task, a series of 21 let-
ters were presented in random order. Each letter was
presented for 250 ms with a 1-s inter-stimulus interval.
Please see Figure 1 for a depiction of the task.
Participants were instructed to respond using a button
press for every letter except the target letter X, which
occurred at a fixed frequency of 10%. A small cross
was shown at the center of the screen during the fix-
ation blocks. Performance variables included reaction
time (RT), number of omissions (failure to respond to
a distractor), and number of commission errors (re-
sponding to an X). Performance accuracy (omissions
only) and mean RT were calculated over all task trials.
The experimental control software was programmed
using Presentation software (v14.9 Neurobehavioral
Systems, Albany, CA, USA) and synchronized by trig-
ger pulse from the MRI scanner. Stimuli were pro-
jected onto a projection screen mounted at the rear of
the magnet via an LCD projector and viewed by way
of a mirror mounted to the head coil.
Statistical Analysis
Statistical analysis of behavioral data was performed
using SPSS 18 for Windows. Descriptive analyses of
demographic and clinical variables were conducted to
characterize the group and to compare participants
with and without fMRI data to establish representa-
tiveness. All interval variable distributions were exam-
ined for normality to determine whether the use of
parametric statistics was appropriate. Frequency com-
parisons (chi-square) were used to compare the pro-
portion of participants with and without HI on
demographic and clinical variables. Mean compari-
sons (e.g., two-sample t-test, one-way analysis of vari-
ance [ANOVA]) were used to compare groups on
continuous variables. Results from tests examining the
hypothesis that greater extent of pre-surgical HI
would be associated with increased sleep dysfunction
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and that sleep dysfunction would predict decreased
CPT performance were considered significant at
p1sided05.
fMRI data were preprocessed and statistically ana-
lyzed using the Statistical Parametric Mapping soft-
ware (SPM 8; Wellcome Department of Imaging
Neuroscience, London). Images were realigned to cor-
rect for interscan head motion (Ashburner, 2009),
normalized to the Montreal Neurological Institute
brain template (Brett, Johnsrude, & Owen, 2002) and
smoothed with a 6-mm full width at half-maximum
Gaussian kernel. The smoothed and normalized
images were resliced to 2-mm isotropic resolution.
Data from individual subjects were analyzed accord-
ing to a fixed-effects general linear model, with task-
related activity modeled as a box-car function
convolved with the canonical hemodynamic response
function (Friston et al., 1995). After parameter estima-
tion, contrasts were generated reflecting the
task> fixation and subsequently used as variables in
second-level random-effect analyses to identify pat-
terns of brain activation for the group as a whole.
A two-sample independent t-test was used to examine
patterns of activation by groups based on HI and
groups based on EDS. Unless otherwise specified, acti-
vation was considered significant at p .05, family-
wise error corrected for multiple comparisons and
with a minimum cluster size of 5 voxels (Friston,
Worsley, Frackowiak, Mazziotta, & Evans, 1994).
The anatomical name and Brodmann area (BA) re-
ported for each supratentorial cluster of activation
were determined by visual comparison with the
Talairach atlas (Talairach and Tournoux, 1988) and
the MRI atlas of the cerebellum developed by
Schmahmann et al. (1999).
We conducted an exploratory analysis on the fMRI
data using effect size thresholds as opposed to conven-
tional significance thresholds (i.e., p-values). Although
we stress that this approach is used primarily to gener-
ate rather than test hypotheses, it is advantageous
when used with small data sets to reduce the risk of
Type II error. Specifically, we conducted two add-
itional second-level random effects between-groups
analyses using a liberal threshold (p .05 uncorrected,
cluster threshold of 20 voxels). The contrast of interest
was task> fixation. The first analyses compared
theþEDS and –EDS groups and the second compared
the þHI and –HI groups. Based on these analyses, we
generated effect size plots for significant local max-
ima. We present only those clusters where the lower
confidence interval bound is 0.4 standard deviations
from the mean, a value that is consistent with a me-
dium effect size.
Results
Participant Characteristics
Of the 62 participants who completed the sleep study,
23 did not meet eligibility criteria for participation in
the fMRI exam (17 participants were under 8 years of
age, two participants were not cleared for the 3T mag-
net, one participant did not speak English, and two
participants had sensorimotor limitations). Data were
successfully collected in 29 of the 39 eligible patients
(74%). Reasons for missing fMRI data were as
follows: scheduling difficulties¼ two, patient anx-
iety¼ three, and scan quality limited by motion¼
five). As detailed in Table I, participants in theþ fMRI
cohort had significantly fewer surgeries before study
enrollment when compared with the –fMRI cohort
(1.060.8 vs. 1.66 0.8, p¼ .044). Although the mean
FSIQ in both groups was within age expectations, the
mean FSIQ in the þfMRI cohort was significantly
higher than that in the –fMRI cohort (105.0614.7 vs.
93.36 14.4, p¼ .037). TheþfMRI and –fMRI cohorts
did not significantly differ on the extent of HI
(p¼ 0.242). In contrast, there was a significantly
greater frequency of þEDS participants in the –fMRI
cohort compared with the þfMRI cohort (100% vs.
69%, respectively; p¼ .045).
Rates of EDS
Before adjuvant proton therapy, 76% of the overall
group met MSLT-based criteria for EDS. The majority
of patients (57%) had Grade 2 pre-surgical HI.
Results of the chi-square analysis revealed a higher fre-
quency of Grade 2 HI in participants with EDS com-
pared with those without EDS (64% vs. 33%,
p¼0.04; Table II). Results of one-way ANOVAs re-
vealed a significant difference in MSLT mean SOL by
HI grade (p< 0.0001). Post hoc comparisons revealed
significant differences between Grade 0 (13.56 4.8)
and Grade 2 (6.165.0; p¼< .0001), and Grade 1
(9.265.8) and Grade 2 (p¼ .05) only; as such,
Grades 0 and 1 were combined for subsequent fMRI
analysis, consistent with the approach of Ozyurt et al.
(2014). There was no significant difference in the
total number of SOREMPs by HI grade (p¼ .23).
Figure 1. Stimulus paradigm used for the CPT task.
Reprinted with permission from Ogg et al. 2008.
Sleep and Cognition in Children With Craniopharyngioma 615
fMRI-CPT
Accuracy on the fMRI-CPT was high for the overall
group (% omission errors M¼ 6.55, SD¼ 6.42).
There were no significant differences in performance
accuracy (p¼ .23) or RT (p¼ .48) based on HI (low
grade vs. high grade) or EDS (Table III). Sites of sig-
nificant activation for the overall group during task
performance are detailed in Table IV. Figure 2 depicts
sites with significantly greater activation during task
periods relative to fixation (CPT> fixation) for the
overall group and separately for the þEDS and –EDS
groups. Sites of significant task-related activation are
shown separately for the overall group, the low–grade
HI group, and the high-grade HI group in Figure 3.
Between-group comparisons revealed no significant
differences in neural activation between the low- and
high-grade groups or the þEDS and –EDS groups;
however, visual examination of the group composite
images reveals a greater extent of spatial activation in
the frontal cortical regions (superior frontal gyrus,
dorsal frontal gyrus) for the þEDS group.
Exploratory analyses based on effect size thresh-
olds revealed differences based on subgroup
(Supplementary Table I and Figures 1 and 2).
Compared with the þEDS group, greater activation
was found in the –EDS in the left inferior occipital
temporal gyri; right visual processing and association
cortex (lingual gyrus, cuneus, and precuneus); and left
precentral and postcentral gyri. Differences in activa-
tion between the low- and high-grade groups were
seen in the left superior parietal lobe (low>high) and
bilateral superior frontal gyrus (high> low).
Discussion
This study examined the role of HI on sleep and neu-
rocognitive sequalae in a cohort of patients complet-
ing treatment for childhood craniopharyngioma, with
the broader goal of gaining insight into predictors and
underlying mechanisms of morbidity in these vulner-
able survivors. To our knowledge, this is the first
study that uses fMRI to examine underlying mechan-
isms related to disease and treatment sequalae in a co-
hort of patients who are naı¨ve to radiation therapy.
Findings support our a priori hypothesis regarding
the association of HI and daytime sleepiness in sur-
vivors. Patients with a greater extent of HI are more
likely to meet objective, standardized criteria for clin-
ically significant EDS. This finding underscores the
predictive role of the extent of pre-surgical HI on out-
comes related to quality of life in survivors. Results
may also have implications for treatment decision-
making, given that the adverse consequences of hypo-
thalamic damage are present before adjuvant
treatment.
We found no evidence of significant differences in
fMRI-CPT performance based on greater extent of HI
or EDS. Mean error rates for the fMRI-CPT ranged
from 6% to 7% when examined by subgroups based
on extent of HI or EDS. This finding is somewhat con-
trary to our expectations, given the findings of relative
deficits in performance on sustained attention tasks in
children with poor sleep and in patients with greater
extent of HI. However, it is important to note that the
5-min duration of our task is much shorter than stand-
ardized continuous performance measures used to as-
sess sustained attention in clinical settings. Further,
given the significantly higher rate of EDS in partici-
pants in the –fMRI cohort compared with the þfMRI
cohort limit, these findings may underestimate the dif-
ference in sustained attention performance between
these groups.
Patterns of neural activation in the overall group
were comparable with previous findings in healthy
control studies using the fMRI-CPT task (Ogg et al.,
2008). Results of between-group comparisons did not
reach significance in analyses corrected for multiple
comparisons; however, group differences are evident
on visual inspection of contrasts displayed at the same
statistical threshold, in areas previously found to be
associated with performance on CPT tasks in healthy
children and adults (Ogg et al., 2008; Wang et al.,
2013). We stress that this is a preliminary analysis of
data from an ongoing study and that differences in ac-
tivation patterns between groups did not reach strict
statistical thresholds corrected for multiple compari-
sons. Nonetheless, our findings are interesting, par-
ticularly in the context of similar performance
between groups. Specifically, the finding of increased
spatial extent of activation within the frontal lobe re-
gions for the þEDS cohort is consistent with expect-
ations based on a compensatory activation hypothesis
(Shaywitz & Shaywitz, 2008). The low-grade HI
group appeared to have a larger spatial extent of task-
related activation in temporal and parietal regions
when visually compared with the high-grade HI
group, suggesting that the low-grade group has relied
on different cortical regions to achieve a similar level
of performance.
Table II. Frequency of Excessive Daytime Sleepiness by
Hypothalamic Involvement
þEDS n¼47 EDS n¼ 15 pa
% % %
Hypothalamic involvement 0.04
Grade 0 8.5 26.7
Grade 1 27.7 40.0
Grade 2 63.8 33.0
Note. EDS¼Excessive daytime sleepiness.
aOne-sided p-value from comparisons (chi-square) between þEDS
and EDS cohorts.
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Exploratory between-groups comparisons were con-
ducted in an effort to generate data to inform hypotheses
to be tested in future studies. Results revealed preliminary
evidence of differences between subgroups of at least a
moderate effect size (90% confidence interval lower limit:
d 0.3). We found a greater spatial extent of activation
in the EDS group when compared with the þEDS
group in posterior brain regions, including the occipital
and temporal cortex. Although preliminary, these results
suggest compensatory activation because patients without
EDS appear to be relying less on frontal brain regions for
a sustained attention task, thus performance is less effort-
ful and more automatic. Our findings differences in the
pattern of activation in the low- and high-grade HI groups
provide further support for the hypothesis that the groups
may engage different cortical regions to achieve similar
performance. Again, these findings are preliminary; how-
ever, they may provide direction for future analyses based
on a priori regions of interest.
Limitations
Our findings should be considered in light of study
limitations. Patients younger than 6 years old were
excluded from MSLT, which limits generalizability.
Similarly, findings from the fMRI exams may not re-
flect neural activation patterns for patients younger
than 8 years of age. Group differences between the
þfMRI and fMRI cohort on demographic and
Table III. FMRI-CPT Performance by Hypothalamic Involvement and Excessive Daytime Sleepiness
Hypothalamic involvement Excessive daytime sleepiness
Low grade High grade EDS þEDS
M6 SD M6 SD pa M6 SD M6 SD pa
fMRI-CPT
Accuracy 6.66 5.8 6.56 7.4 0.48 7.36 7.0 6.26 6.3 0.34
Reaction time 0.46 0.1 0.36 0.1 0.23 0.46 0.1 0.46 0.1 0.44
Note. CPT¼Continuous performance test.
aOne-sided p-value from mean comparisons between groups.
Table IV. Regional Activation During fMRI-CPT
BA Talairach coordinates Volume Max T
X Y Z mm3
CPT> fixation
R Dorsal frontal gyrus 6 4 18 44 56,152 9.74
R Superior/middle frontal gyrus 6 42 0 58 9.21
R Dorsal frontal gyrus 6 2 6 50 8.86
L Precentral gyrus 4 46 26 64 29,168 8.53
L Precentral gyrus 4 44 10 56 8.50
L Precentral gyrus 4 38 24 58 8.26
L Superior temporal gyrus, lateral sulcus 40 50 24 18 2,736 7.12
L Postcentral gyrus 40/2 62 20 24 6.79
R Cerebellum (VIIAt) 2 78 22 6,360 6.88
R Cerebellum (V) 14 50 22 6.29
R Cerebellum (VI) 30 52 28 6.23
R Thalamus (medial dorsal nucleus) 2 16 12 8,544 6.47
R Cerebral peduncle 2 28 0 6.29
L Thalamus (medial dorsal nucleus) 14 16 10 6.25
L Inferior occipital gyrus 19 38 86 12 1,048 6.28
R Inferior parietal lobe 40 44 52 56 1,352 6.00
L Cerebellum (VI) 32 60 28 736 5.77
R Supramarginal gyrus 40 62 38 28 816 5.75
R Fusiform gyrus 19 52 68 14 80 5.38
R Inferior/Middle occipital gyrus 18 42 84 8 144 5.13
R Cuneus 17 20 100 0 48 5.08
L Middle frontal gyrus 46 36 46 22 64 5.04
Fixation>CPT
R Postcentral gyrus 7 22 50 76 280 5.09
Note. R¼Right, L¼Left, BA¼Brodmann area, Max T¼maxiumum value of the T stastistic in the cluster.
Results of a random-effects analysis, p .05, FWE-corrected, and cluster size5 voxels. Volume of activation reported for regions that are
also significant at p .05, cluster-corrected.
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clinical characteristics further limit the generalizability
of our findings. Specifically, the higher rate of þEDS,
higher mean number of surgeries, and lower mean
FSIQ in the fMRI cohort suggest that those partici-
pants who were eligible but did not complete the
fMRI portion of the study were more impaired than
those in the þfMRI cohort. The absence of data
from a healthy control cohort limits our ability to in-
terpret findings of equivalent performance in pa-
tient groups. Our sample size is consistent with
recommendations for fMRI studies of healthy adults
(Desmond & Glover, 2002); however, our ability to
detect statistically significant differences between
groups may be decreased due to developmentally
based physiological differences (Gaillard, Grandin, &
Xu, 2001). Finally, the study was limited by a single
night PSG, which may be impacted by the first night
effect and thus not provide the full picture of a child’s
sleep that occurs in the habitual sleep environment
(Verhulst, Schrauwen, De Backer, & Desager, 2006).
Figure 2. Brain activity during the CPT task as compared with fixation for the overall group (N¼29), the þEDS group
(n¼20), and the –EDS group (n¼9). Sites with significantly greater activation during task relative to fixation
(CPT>fixation) are shown in green for the overall group, violet for the þEDS group, and yellow for the –EDS group.
Random-effects analysis, p .05, voxel-corrected FWE, and cluster size of 5 voxels. Results are shown on an average
structural image created from a template. Images are shown in neurological convention (left on left).
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Implications
Before adjuvant proton therapy, the vast majority of
patients in our study met criteria for clinically signifi-
cant daytime sleepiness. These results have implications
for the timing and focus of interventions to remediate
difficulties in survivors. Routine clinical follow-up dur-
ing the early survivorship period should screen for sleep
problems, with a particular focus on EDS. Remediation
of sleep dysfunction should be a priority, to maximize
adherence to interventions (e.g., to promote physical
activity and offset potential weight gain related to
hypothalamic injury). Further, sleep restriction in
healthy adolescents has been linked to functional
outcomes, including decreased attention, learning diffi-
culties, mood dysregulation, and increased consump-
tion of foods with a high glycemic index (Baum et al.,
2014; Beebe, Rose, & Amin, 2010; Beebe et al., 2013).
This project makes a significant contribution to the lit-
erature on sleep in pediatric conditions, given the rarity
of craniopharyngioma and challenges related to fMRI
in children with supratentorial tumors. We successfully
collected fMRI data on 71% of patients who completed
baseline sleep exams and met MRI eligibility criteria,
suggesting that functional neuroimaging studies are
feasible in children 8 years of age or older with complex
medical conditions.
Figure 3. Brain activity during the CPT task as compared with fixation depicted for the overall group (N¼29), the low-grade
HI group (n¼ 16), and high-grade HI group (n¼13). Sites with significantly greater activation during task relative to fixation
(CPT>fixation) are shown in green for the overall group, yellow for the low-grade HI group, and violet for the high-grade
HI group. Random-effects analysis, p .05, voxel-corrected FWE, and cluster size of 5 voxels. Results are shown on an
average image created from a template. Images are shown in neurological convention (left on left).
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Supplementary Data
Supplementary data can be found at: http://www.jpepsy.
oxfordjournals.org/.
Funding
This work was supported by the National Cancer Institute
(St. Jude Cancer Center Support, CORE, grant number P30
CA21765), the American Lebanese Syrian Associated
Charities (ALSAC), and the National Cancer Institute
(Pediatric Oncology Education Program, grant number
R25CA23944).
Conflicts of interest: None declared.
References
Ashburner, J. (2009). Computational anatomy with the SPM
software. Magnetic Resonance Imaging, 27, 1163–1174.
doi: 10.1016/j.mri.2009.01.006
Astill, R. G., Van der Heijden, K. B., Van Ijzendoorn, M. H.,
& Van Someren, E. J. (2012). Sleep, cognition, and behav-
ioral problems in school-age children: A century of
research meta-analyzed. Psychological Bulletin, 138,
1109–1138. doi: 10.1037/a0028204
Baum, K. T., Desai, A., Field, J., Miller, L. E., Rausch, J., &
Beebe, D. W. (2014). Sleep restriction worsens mood and
emotion regulation in adolescents. Journal of Child
Psychology and Psychiatry, 55, 180–190. doi: 10.1111/
jcpp.12125
Beebe, D. W., Rose, D., & Amin, R. (2010). Attention, learn-
ing, and arousal of experimentally sleep-restricted adoles-
cents in a simulated classroom. Journal of Adolescent
Health, 47, 523–525. doi: 10.1016/j.jadohealth.2010.
03.005
Beebe, D. W., Simon, S., Summer, S., Hemmer, S., Strotman,
D., & Dolan, L. M. (2013). Dietary intake following ex-
perimentally restricted sleep in adolescents. Sleep, 36,
827–834. doi: 10.5665/sleep.2704
Born, J., & Wilhelm, I. (2012). System consolidation of
memory during sleep. Psychological Research, 76,
192–203. doi: 10.1007/s00426-011-0335-6
Brett, M., Johnsrude, I. S., & Owen, A. M. (2002). The prob-
lem of functional localization in the human brain. Nature
Reviews: Neuroscience, 3, 243–249. doi: 10.1038/nrn756
Caldarelli, M., Massimi, L., Tamburrini, G., Cappa, M., &
Di Rocco, C. (2005). Long-term results of the surgical
treatment of craniopharyngioma: The experience at the
Policlinico Gemelli, Catholic University, Rome. Child’s
Nervous System, 21, 747–757. doi: 10.1007/s00381-005-
1186-5
Carpentieri, S. C., Waber, D. P., Scott, R. M., Goumnerova,
L. C., Kieran, M. W., Cohen, L. E., . . . Pomeroy, S. L.
(2001). Memory deficits among children with craniophar-
yngiomas. Neurosurgery, 49, 1053–1057; discussion
1057–1058.
Clanton, N. R., Klosky, J. L., Li, C., Jain, N., Srivastava, D.
K., Mulrooney, D., . . . Krull, K. R. (2011). Fatigue, vital-
ity, sleep, and neurocognitive functioning in adult sur-
vivors of childhood cancer: A report from the Childhood
Cancer Survivor Study. Cancer, 117, 2559–2568. doi:
10.1002/cncr.25797
de Vile, C. J., Grant, D. B., Hayward, R. D., Kendall, B. E.,
Neville, B. G. R., & Stanhope, R. (1996). Obesity in child-
hood craniopharyngioma: Relation to post-operative
hypothalamic damage shown by magnetic resonance imag-
ing. Journal of Clinical Endocrinology and Metabolism,
81, 2734–2737.
Desmond, J. E., & Glover, G. H. (2002). Estimating sample
size in functional MRI (fMRI) neuroimaging studies:
Statistical power analyses. Journal of Neuroscience
Methods, 118, 115–128.
Di Pinto, M., Conklin, H. M., Li, C., & Merchant, T. E.
(2012). Learning and memory following conformal radi-
ation therapy for pediatric craniopharyngioma and low-
grade glioma. International Journal of Radiation
Oncology, Biology, Physics, 84, e363–e369. doi: 10.1016/
j.ijrobp.2012.03.066
Fjalldal, S., Holmer, H., Rylander, L., Elfving, M., Ekman,
B., Osterberg, K., & Erfurth, E. M. (2013). Hypothalamic
involvement predicts cognitive performance and psychoso-
cial health in long-term survivors of childhood craniophar-
yngioma. The Journal of Clinical Endocrinology and
Metabolism, 98, 3253–3262. doi: 10.1210/jc.2013-2000
Friston, K. J., Holmes, A. P., Poline, J. B., Grasby, P. J.,
Williams, S. C., Frackowiak, R. S., & Turner, R. (1995).
Analysis of fMRI time-series revisited. Neuroimage, 2,
45–53. doi: 10.1006/nimg.1995.1007
Friston, K. J., Worsley, K. J., Frackowiak, R. S., Mazziotta,
J. C., & Evans, A. C. (1994). Assessing the significance of
focal activations using their spatial extent. Human Brain
Mapping, 1, 210–220. doi: 10.1002/hbm.460010306
Gaillard, W. D., Grandin, C. B., & Xu, B. (2001).
Developmental aspects of pediatric fMRI: considerations
for image acquisition, analysis, and interpretation.
Neuroimage, 13, 239–249. doi: 10.1006/nimg.2000.0681
Gapstur, R., Gross, C. R., & Ness, K. (2009). Factors associ-
ated with sleep-wake disturbances in child and adult sur-
vivors of pediatric brain tumors: A review. Oncology
Nursing Forum, 36, 723–731. doi: 10.1188/09.ONF.
723-731
Garre, M. L., & Cama, A. (2007). Craniopharyngioma:
Modern concepts in pathogenesis and treatment. Current
Opinion in Pediatrics, 19, 471–479. doi: 10.1097/
MOP.0b013e3282495a22
Gooley, J. J., & Saper, C. B. (2011). Anatomy of the mam-
malian circadian system. In M. H. Kryger, T. Roth, M. H.
Kryger, & W. C. Dement (Eds.), Principle and practice of
sleep medicine (5th ed.). St. Louis, MO: Elsevier.
Graef DM, Conklin H, Sykes A, Ashford J, Wise M,
Mandrell BN, . . . Crabtree V, Excessive daytime sleepiness
and neurocognitive performance in pediatric patients with
craniopharyngioma. SLEEP Conference. Seattle, WA.
June, 2015
Hakim, F., Wang, Y., Zhang, S. X., Zheng, J., Yolcu, E. S.,
Carreras, A., . . . Gozal, D. (2014). Fragmented sleep ac-
celerates tumor growth and progression through recruit-
ment of tumor-associated macrophages and TLR4
signaling. Cancer Research, 74, 1329–1337. doi: 10.1158/
0008-5472.CAN-13-3014
620 Jacola et al.
Lemaire, J. J., Frew, A. J., McArthur, D., Gorgulho, A. A.,
Alger, J. R., Salomon, N., . . . De Salles, A. A. (2011). White
matter connectivity of human hypothalamus. Brain
Research, 1371, 43–64. doi: 10.1016/j.brainres.2010.11.072
Lipton, J., Megerian, J. T., Kothare, S. V., Cho, Y. J.,
Shanahan, T., Chart, H., . . . Pomeroy, S. L. (2009).
Melatonin deficiency and disrupted circadian rhythms in
pediatric survivors of craniopharyngioma. Neurology, 73,
323–325. doi: 10.1212/WNL.0b013e3181af78a5
Mandrell, B. N., Wise, M., Schoumacher, R. A., Pritchard, M.,
West, N., Ness, K. K., . . . Morris, B. (2012). Excessive daytime
sleepiness and sleep-disordered breathing disturbances in sur-
vivors of childhood central nervous system tumors. Pediatric
Blood and Cancer, 58, 746–751. doi: 10.1002/pbc.23311
Melendres, M. C., Lutz, J. M., Rubin, E. D., & Marcus, C. L.
(2004). Daytime sleepiness and hyperactivity in children
with suspected sleep-disordered breathing. Pediatrics, 114,
768–775. doi: 10.1542/peds.2004-0730
Moore, M., Kirchner, H. L., Drotar, D., Johnson, N., Rosen,
C., Ancoli-Israel, S., & Redline, S. (2009). Relationships
among sleepiness, sleep time, and psychological function-
ing in adolescents. Journal of Pediatric Psychology, 34,
1175–1183. doi: 10.1093/jpepsy/jsp039
Muller, H. L. (2008). Childhood craniopharyngioma. Recent
advances in diagnosis, treatment and follow-up. Hormone
Research, 69, 193–202. doi: 10.1159/000113019
Muller, H. L. (2010). Increased daytime sleepiness in patients
with childhood craniopharyngioma and hypothalamic
tumor involvement: Review of the literature and perspec-
tives. International Journal of Endocrinology, 2010,
519607. doi: 10.1155/2010/519607
Muller, H. L., Gebhardt, U., Teske, C., Faldum, A., Zwiener,
I., Warmuth-Metz, M., . . . Calaminus, G.; Study
Committee of KRANIOPHARYNGEOM 2000. (2011).
Post-operative hypothalamic lesions and obesity in child-
hood craniopharyngioma: Results of the multinational
prospective trial KRANIOPHARYNGEOM 2000 after
3-year follow-up. European Journal of Endocrinology,
165, 17–24. doi: 10.1530/EJE-11-0158
Muller, H. L., Handwerker, G., Gebhardt, U., Faldum, A.,
Emser, A., Kolb, R., & Sorensen, N. (2006). Melatonin
treatment in obese patients with childhood craniopharyng-
ioma and increased daytime sleepiness. Cancer Causes and
Control, 17, 583–589. doi: 10.1007/s10552-005-9012-7
Muller, H. L., Handwerker, G., Wollny, B., Faldum, A., &
Sorensen, N. (2002). Melatonin secretion and increased day-
time sleepiness in childhood craniopharyngioma patients.
The Journal of Clinical Endocrinology and Metabolism, 87,
3993–3996. doi: 10.1210/jcem.87.8.8751
National Cancer Institute. (2015). Retrieved from http://
www.cancer.net/cancer-types/craniopharyngioma-child
hood/statistics
Nolan, V. G., Gapstur, R., Gross, C. R., Desain, L. A.,
Neglia, J. P., Gajjar, A., . . . Ness, K. K. (2013). Sleep dis-
turbances in adult survivors of childhood brain tumors.
Quality of Life Research, 22, 781–789. doi: 10.1007/
s11136-012-0208-5
Ogg, R. J., Zou, P., Allen, D. N., Hutchins, S. B.,
Dutkiewicz, R. M., & Mulhern, R. K. (2008). Neural cor-
relates of a clinical continuous performance test. Magnetic
Resonance Imaging, 26, 504–512. doi: 10.1016/
j.mri.2007.09.004
Ozyurt, J., Lorenzen, A., Gebhardt, U., Warmuth-Metz, M.,
Muller, H. L., & Thiel, C. M. (2014). Remote effects of
hypothalamic lesions in the prefrontal cortex of cranio-
pharygioma patients. Neurobiology of Learning and
Memory, 111, 71–80. doi: 10.1016/j.nlm.2014.03.007
Ozyurt, J., Thiel, C. M., Lorenzen, A., Gebhardt, U.,
Calaminus, G., Warmuth-Metz, M., & Muller, H. L.
(2014). Neuropsychological outcome in patients with
childhood craniopharyngioma and hypothalamic involve-
ment. The Journal of Pediatrics, 164, 876–881.e874. doi:
10.1016/j.jpeds.2013.12.010
Pierre-Kahn, A., Recassens, C., Pinto, G., Thalassinos, C.,
Chokron, S., Soubervielle, J. C., . . . Sainte Rose, C.
(2005). Social and psycho-intellectual outcome following
radical removal of craniopharyngiomas in childhood: A
prospective series. Child’s Nervous System, 21, 817–824.
doi: 10.1007/s00381-005-1205-6
Poretti, A., Grotzer, M. A., Ribi, K., Schonle, E., & Boltshauser,
E. (2004). Outcome of craniopharyngioma in children: Long-
term complications and quality of life. Developmental
Medicine and Child Neurology, 46, 220–229.
Rosen, G. M., Shor, A. C., & Geller, T. J. (2008). Sleep in
children with cancer. Current Opinion in Pediatrics, 20,
676–681.
Schmahmann, J. D., Doyon, J., McDonald, D., Holmes, C.,
Lavoie, K., Hurwitz, A. S., . . . Petrides, M. (1999). Three-
dimensional MRI atlas of the human cerebellum in propor-
tional stereotaxic space. Neuroimage, 10(3 Pt 1),
233–260. doi: 10.1006/nimg.1999.0459
Shaywitz, S. E., & Shaywitz, B. A. (2008). Paying attention
to reading: The neurobiology of reading and dyslexia.
Development and Psychopathology, 20, 1329–1349. doi:
10.1017/S0954579408000631
Sterkenburg, A. S., Hoffmann, A., Gebhardt, U., Warmuth-
Metz, M., Daubenbuchel, A. M., & Muller, H. L. (2015).
Survival, hypothalamic obesity, and neuropsychological/
psychosocial status after childhood-onset craniopharyng-
ioma: Newly reported long-term outcomes. Neuro-oncol-
ogy, 17, 1029–1038. doi: 10.1093/neuonc/nov044
Talairach, J., & Tournoux, P. (1988). Co-planar sereotaxic
atlas of the human brain. New York, NY: Thieme.
Verberne, L. M., Maurice-Stam, H., Grootenhuis, M. A.,
Van Santen, H. M., & Schouten-Van Meeteren, A. Y.
(2012). Sleep disorders in children after treatment for a
CNS tumour. Journal of Sleep Research, 21, 461–469. doi:
10.1111/j.1365-2869.2011.00971.x
Verhulst, S. L., Schrauwen, N., De Backer, W. A., &
Desager, K. N. (2006). First night effect for polysomno-
graphic data in children and adolescents with suspected
sleep disordered breathing. Archives of Disease in
Childhood, 91, 233–237. doi: 10.1136/adc.2005.085365
Waber, D. P., Pomeroy, S. L., Chiverton, A. M., Kieran, M.
W., Scott, R. M., Goumnerova, L. C., & Rivkin, M. J.
(2006). Everyday cognitive function after craniopharyng-
ioma in childhood. Pediatric Neurology, 34, 13–19. doi:
10.1016/j.pediatrneurol.2005.06.002
Walker, M. P., & van der Helm, E. (2009). Overnight therapy?
The role of sleep in emotional brain processing. Psychological
Bulletin, 135, 731–748. doi: 10.1037/a0016570
Sleep and Cognition in Children With Craniopharyngioma 621
Wang, S., Yang, Y., Xing, W., Chen, J., Liu, C., & Luo, X.
(2013). Altered neural circuits related to sustained atten-
tion and executive control in children with ADHD: An
event-related fMRI study. Clinical Neurophysiology, 124,
2181–2190. doi: 10.1016/j.clinph.2013.05.008
Wechsler, D. (2003). WISC-IV Wechsler Intelligence Scale for
Children: Technical and Interpretative: Manual. San
Antonio, TX: Pearson.
Weissman, D. H., Roberts, K. C., Visscher, K. M., &
Woldorff, M. G. (2006). The neural bases of momentary
lapses in attention. Nature Neuroscience, 9, 971–978. doi:
10.1038/nn1727
Zhou, E. S., Manley, P. E., Marcus, K. J., & Recklitis, C. J.
(2016). Medical and psychosocial correlates of insomnia
symptoms in adult survivors of pediatric brain tumors.
Journal of Pediatric Psychology, 41, 623–630.
622 Jacola et al.
